ScholarIQanswers from OpenAlex

Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential

PaperCitations, authors & open-access status

Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential have?

ScholarIQcitation count

Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential has 443 citations in the OpenAlex counts ScholarIQ stores.

When was Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential published?

ScholarIQyear

Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential has 2010 year in the ScholarIQ index.

What is the open-access status of Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential?

ScholarIQoa status

Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential has closed oa status in the ScholarIQ index.

What is the DOI of Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential?

ScholarIQdoi

The DOI for Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential is on the source record.

What is the PMID of Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential?

ScholarIQpmid

The PMID for Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential is on the source record.

What is the OpenAlex record for Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential?

ScholarIQopenalex

The OpenAlex for Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial